- Home
- FBRT vs TXG Comparison
FBRT vs TXG Comparison
Compare FBRT & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBRT
- TXG
- Stock Information
- Founded
- FBRT 2012
- TXG 2012
- Country
- FBRT United States
- TXG United States
- Employees
- FBRT N/A
- TXG N/A
- Industry
- FBRT Real Estate Investment Trusts
- TXG Biotechnology: Laboratory Analytical Instruments
- Sector
- FBRT Real Estate
- TXG Industrials
- Exchange
- FBRT Nasdaq
- TXG Nasdaq
- Market Cap
- FBRT 933.1M
- TXG 1.0B
- IPO Year
- FBRT 1985
- TXG 2019
- Fundamental
- Price
- FBRT $11.56
- TXG $9.65
- Analyst Decision
- FBRT Strong Buy
- TXG Buy
- Analyst Count
- FBRT 6
- TXG 15
- Target Price
- FBRT $15.25
- TXG $17.65
- AVG Volume (30 Days)
- FBRT 450.6K
- TXG 4.1M
- Earning Date
- FBRT 04-28-2025
- TXG 05-08-2025
- Dividend Yield
- FBRT 12.23%
- TXG N/A
- EPS Growth
- FBRT N/A
- TXG N/A
- EPS
- FBRT 0.67
- TXG N/A
- Revenue
- FBRT $175,693,000.00
- TXG $624,662,000.00
- Revenue This Year
- FBRT $24.81
- TXG $0.45
- Revenue Next Year
- FBRT $4.20
- TXG $9.00
- P/E Ratio
- FBRT $17.33
- TXG N/A
- Revenue Growth
- FBRT N/A
- TXG N/A
- 52 Week Low
- FBRT $10.50
- TXG $6.78
- 52 Week High
- FBRT $14.12
- TXG $28.25
- Technical
- Relative Strength Index (RSI)
- FBRT 49.62
- TXG 62.04
- Support Level
- FBRT $11.06
- TXG $7.72
- Resistance Level
- FBRT $11.54
- TXG $10.15
- Average True Range (ATR)
- FBRT 0.25
- TXG 0.53
- MACD
- FBRT 0.07
- TXG 0.23
- Stochastic Oscillator
- FBRT 81.72
- TXG 79.42
About FBRT Franklin BSP Realty Trust Inc.
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. Its segments include the real estate debt business; the real estate securities business; the real estate owned business; and the commercial real estate conduit business.
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).